-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Author Archive: Roy Zwahlen
Roy is a Manager of Intellectual Property and Technology Transfer policy at BIO and the main contributor for Patently Biotech. He is a lawyer by training, with a background in international and national politics. He grew up in the developing world and believes that innovation can and does solve many of the world’s problems. Because of this, his work focuses on creating a worldwide policy environment that fosters innovation in the biotechnology sector to prevent and cure diseases such as HIV, to increase crop yields to feed more people, and to decrease the harmful effects of industry on the environment. Roy spends his free time keeping up with his two kids, a wife that knows everything (no joke), and serving in his church and broader community. Learn more about Roy from his Linkedin Profile.
Latest Posts
BIO Urges Supreme Court to Reject Rigid Bilski Rule
In an amicus brief filed today, BIO urged the Supreme Court to overturn the decision of the U.S. Court of Appeals for the Federal Circuit in Bilski v. Doll.
BIO Marks Passing of Stanford Professor Emeritus John Barton: ‘Far Ahead of his Time’
On August 3, 2009, John H. Barton, George E. Osborne Professor of Law, Emeritus at Stanford Law School, passed away. BIO marks his early passing by remembering his focused personal commitment and intellectual drive to understand, teach, and shape legal science and technology policy. Barton spoke to the IP Counsels Committee at a previous IP Counsels Committee Conference, in 2008. A few of his accomplishments and goals (Stanford): John Barton devoted his academic career to Read More >
Innovation Alliance: Patent Holders Weigh In On Patent Reform
Check out this new video on patent reform from the Innovation Alliance.
House Energy and Commerce Committee Vote Marks Another Step Forward on Pathway to Biosimilars
House Energy and Commerce Committee Vote Marks Another Step Forward on Pathway to Biosimilars Strong bipartisan support for inclusion of pathway in health care reform legislation Washington, D.C. (July 31, 2009) – Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following statement on the approval of an amendment to create a regulatory pathway for biosimilars by the House Energy and Commerce Committee in today’s mark-up of the America’s Affordable Health Choices Act Read More >
Technology Transfer Symposium at BIO Investor Forum
Technology Transfer Symposium: Promoting Public-Private Collaboration for Innovation Wednesday October 28, 2009 7:30 am – 12 pm PT The Palace Hotel San Francisco, CA The Technology Transfer Symposium, held in conjunction with the BIO Investor Forum, will explore the domestic and international policy challenges for professionals in university, industry, and legal areas regarding the administration of technology transfer. This groundbreaking meeting will bring together stakeholder groups to discuss the challenges and opportunities of today’s Read More >
